For most patients, a diagnosis is just the beginning of an uncertain journey filled with long wait times, fragmented ...
EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a robotic endoluminal system for gastrointestinal procedures. The ...
EndoQuest Robotics announced today that the FDA approved the initiation of the next and final stage of its PARADIGM trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback